Background: Magnetic resonance (MR) imaging is frequently used to diagnose arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D). However, the reliability of various MR imaging features for diagnosing ARVC/D is unknown. The purpose of this study was to determine which morphologic MR imaging features have the greatest interobserver reliability for diagnosing ARVC/D. Methods: Forty-five sets of films of cardiac MR images were sent to 8 radiologists and 5 cardiologists with experience in this field. There were 7 cases of definite ARVC/D as defined by the Task Force criteria. Six cases were controls. The remaining 32 cases had MR imaging because of clinical suspicion of ARVC/D. Readers evaluated the images for the presence of (a) right ventricle (RV) enlargement, (b) RV abnormal morphology, (c) left ventricle enlargement, (d) presence of high T1 signal (fat) in the myocardium, and (e) location of high T1 signal (fat) on a Likert scale with formatted responses. Results: Readers indicated that the Task Force ARVC/D cases had significantly more (χ2 = 119.93, d.f. = 10, p < 0.0001) RV chamber size enlargement (58%) than either the suspected ARVC/D (12%) or no ARVC/D (14%) cases. When readers reported the RV chamber size as enlarged they were significantly more likely to report the case as ARVC/D present (χ2= 33.98, d.f. = 1, p < 0.0001). When readers reported the morphology as abnormal they were more likely to diagnose the case as ARVC/D present (χ2 = 78.4, d.f. = 1, p < 0.0001), and the Task Force ARVC/D (47%) cases received significantly more abnormal reports than either suspected ARVC/D (20%) or non-ARVC/D (15%) cases. There was no significant difference between patient groups in the reported presence of high signal intensity (fat) in the RV (χ2 = 0.9, d.f. = 2, p > 0.05). Conclusions: Reviewers found that the size and shape of abnormalities in the RV are key MR imaging discriminates of ARVD. Subsequent protocol development and multicenter trials need to address these parameters. Essential steps in improving accuracy and reducing variability include a standardized acquisition protocol and standardized analysis with dynamic cine review of regional RV function and quantification of RV and left ventricle volumes.

Keywords:
Magnetic resonance imaging, Diagnosis, Cardiomyopathy, Right ventricle
1.
Marcus FI, Fontaine GH, Guiraudon G, et al: Right ventricular dysplasia: A report of 24 adult cases. Circulation 1982;65:384–398.
2.
Marcus FI, Fontaine G: Arrhythmogenic right ventricular dysplasia/cardiomyopathy. A Review. PACE 1995;18:1298–1314.
3.
Corrado D, Fontaine G, Marcus FI, McKenna WJ, Nava A, Thiene G, Wichter T: Arrhythmogenic right ventricular dysplasia/cardiomyopathy: The need for an International Registry. Circulation 2000;101:e101–e106/J Cardiovasc Electrophysiol 2000;11:827–832.
4.
Marcus FI: Is arrhythmogenic right ventricular dysplasia, Uhl’s anomaly and right ventricular outflow tract tachycardia a spectrum of the same disease? Cardiol Rev 1997;5:25–29.
5.
Boxt LM: Radiology of the right ventricle. Radiol Clin North Am 1999;37:379–400.
6.
McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G, Camerini F: Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. On behalf of the Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology, supported by the Schoepfer Association. Br Heart J 1994;71:215–218.
7.
Blake LM, Scheinman MM, Higgins CB: MR features of arrhythmogenic right ventricular dysplasia. Am J Roentgenol 1994;162:809–812.
8.
Midiri M, Finazzo M, Brancato M, Hoffmann E, Indovina G, Maria MD, Lagalla R: Arrhythmogenic right ventricular dysplasia: MR features. Eur Radiol 1997;7:307–312.
9.
Wichter T, Lentschig MG, Reimer P, et al: Magnetic resonance imaging; in Nava A, Rossi L, Thiene G (eds): Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia. Amsterdam, Elsevier Science BV, 1997, pp 269–284.
10.
Friedrich MG: Magnetic resonance imaging in cardiomyopathies. J Cardiovasc Magn Reson 2000;2:67–82.
11.
Ricci C, Longo R, Pagnan L, Dalla Palma L, Pinamonti B, Camerini F, Bussani R, Silvestri F: Magnetic resonance imaging in right ventricular dysplasia. Am J Cardiol 1992;70:1589–1595.
12.
Kayser, HWM, van der Wall, EE , Sivananthan, MU, Plein, S, Bloomer TN, and de Roos, A: Diagnosis of arrhythmogenic right ventricular dysplasia: A review. Radiographics 2002;22:639–648.
13.
Richardson PJ, McKenna WJ, Bristow M, et al: Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996;93:841–842.
14.
Fontaine G, Fontaliran F, Hebert JL, Chemla D, Zenati O, Lecarpentier Y, Frank R: Arrhythmogenic right ventricular dysplasia. Annu Rev Med 1999;50:17–35.
15.
Kanji GK: 100 Statistical Tests. Thousand Oaks, Sage Publications, 1993, pp 75–76.
16.
Cohen J: A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37–46.
17.
Burke AP, Farb A, Tashko G, Virmani R: Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium. Are they different diseases? Circulation 1998;97:1571–1580.
18.
White RD, Trohman RG, Flamm SD, et al: Right ventricular arrhythmia in the absence of arrhythmogenic dysplasia: MR imaging of myocardial abnormalities. Radiology 1998;207:743–751.
19.
Globits S, Kreiner G, Frank H, Heinz G, Klaar U, Frey B, Gossinger H: Significance of morphological abnormalities detected by MRI in patients undergoing successful ablation of right ventricular outflow tract tachycardia. Circulation 1997;96:2633–2640.
20.
Proclemer A, Basadonna PT, Slavich GA, Miani D, Fresco C, Fioretti PM: Cardiac magnetic resonance imaging findings in patients with right ventricular outflow tract premature contractions. Eur Heart J 1997;18:2002–2010.
21.
Markowitz SM, Litvak BL, Ramirez de Arellano EA, et al: Adenosine-sensitive ventricular tachycardia. Right ventricular abnormalities delineated by magnetic resonance imaging. Circulation 1997;96:1192–1200.
22.
Carlson MD, White RD, Trohman RG, et al: Right ventricular outflow tract ventricular tachycardia: Detection of previously unrecognized anatomic abnormalities using cine magnetic resonance imaging. J Am Coll Cardiol 1994;24:720–727.
23.
Grimm W, List-Hellwig E, Hoffman J, et al: Magnetic resonance imaging and signal-averaged electrocardiography in patients with repetitive monomorphic ventricular tachycardia and otherwise normal electrocardiogram. PACE 1997;20:1826–1833.
24.
Auffermann W, Wichter T, Breithardt G, Joachimsen K, Peters P: Arrhythmogenic right ventricular disease: MR imaging vs. angiography. AJR 1993;161:1549–1555.
25.
Lorenz CH, Walker ES, Morgan VL, Klein SS, Graham TP: Normal human right and left ventricular mass, systolic function and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson 1999;1:7–21.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.